Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine.
Takeda
Y
Y
Second Department of Surgery, Tohoku University School of Medicine, Japan.
Satomi
S
S
Miura
S
S
Koja
S
S
Morimoto
K
K
Okazaki
H
H
Taguchi
Y
Y
Mori
S
S
D015762:2-Chloroadenosine / Q000494:pharmacology*; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D007959:Lymphocyte Culture Test, Mixed; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D012263:Ribonucleosides / Q000494:pharmacology*; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D015762:2-Chloroadenosine; C010052:mizoribine